AdvaCare’s range of oncology medications treat a wide spectrum of cancers, the world’s second leading cause of death. Available as tablets, injections, and powder for injection, we produce more than 45 medications used in the treatment of various types of cancer.
Over 200 different types of known cancers have resulted in the innovation of hundreds of effective medications, many of which are off patent and therefore able to be produced as generic products.
AdvaCare excels at the production of quality, yet cost-effective oncology treatments which are in short supply in developing countries. We aim to reach patients that, due to location or lack of resources, might not be capable to obtain the most effective cancer treatments.
AdvaCare supplies distributors across the developing world with effective oncology products.
*Main markets (by region) for our Oncology product range include: Asia: Armenia, Australia, Bangladesh, Belarus, Brunei, Bhutan, Cambodia, Fiji, Georgia, India, Indonesia, Kazakhstan, Kyrgyzstan, Laos, Malaysia, Micronesia, Mongolia, Myanmar, Nepal, New Zealand, Papua New Guinea, Philippines, Singapore, Solomon Islands, Sri Lanka, Syria, Taiwan, Tajikistan, Thailand, Turkmenistan, Ukraine, Uzbekistan, Vietnam
North America: Anguilla, Antigua and Barbuda, Barbados, Belize, Bermuda, Cayman Islands, Costa Rica, Cuba, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Saint Lucia, Trinidad and Tobago
South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Middle East: Afghanistan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Qatar, Saudi Arabia, United Arab Emirates (UAE), Yemen
Europe: Andorra, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Malta, Moldova, Portugal, Romania, Russia, Slovenia, Slovakia, Serbia, Montenegro
